http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Article/list/43791 Latest news on cataract surgery products and techniques including IOLs, microincision surgery, phacoemulsification, endophthalmitis and complication management. 2013-06-18T06:15:28Z http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Macular-thickness-increases-after-cataract-surgery/ArticleStandard/Article/detail/813260?contextCategoryId=43791&ref=25 Macular thickness significantly increases up to six months after uncomplicated cataract surgery, according to an investigation featured in the journal Eye. 2013-05-22T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202013/813260null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/RDO-patient-pathway-improves-operative-rates-in-ca/ArticleStandard/Article/detail/812639?contextCategoryId=43791&ref=25 Operative rates for cataract surgery are higher for the refined direct optometrist (RDO) patient pathway, compared to the GP pathway, reveals a recent investigation in the UK. 2013-05-15T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812639null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Excellent-visual-outcomes-in-cataract-surgery/ArticleStandard/Article/detail/811396?contextCategoryId=43791&ref=25 Cataract surgery produces excellent visual outcomes, with 61.3% of patients achieving a corrected distance visual acuity of 20/20 or better, according to a database study in the Journal of Cataract and Refractive Surgery. 2013-04-30T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/172013/811396null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/ECD-not-linked-to-CCT-in-keratoconus/ArticleStandard/Article/detail/806762?contextCategoryId=43791&ref=25 Corneal endothelial cell density (ECD) changes are independent from central corneal thickness (CCT) in keratoconus patients, states a recent paper. 2013-03-06T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/092013/806762null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Loteprednol-etabonate-controls-inflammation-and-IO/ArticleStandard/Article/detail/805647?contextCategoryId=43791&ref=25 Loteprednol etabonate controls inflammation and reduces IOP fluctuation after cataract surgery, according to a recent study. 2013-02-21T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072013/805647null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Optos-urges-skiers-to-consider-eye-health/ArticleStandard/Article/detail/804813?contextCategoryId=43791&ref=25 Optos is urging skiers to ensure they take care of their eyesight while on the slopes this winter, according to their latest press release. 2013-02-11T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/062013/804813null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Gel-cuts-inflammation-and-pain/ArticleStandard/Article/detail/804101?contextCategoryId=43791&ref=25 Loteprednol etabonate gel 0.5% is efficacious and safe for treating postoperative inflammation and pain caused by cataract surgery, claims a recent report. 2013-02-07T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/052013/804101null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Povidone-iodine-and-antibiotics-effective-for-cata/ArticleStandard/Article/detail/802869?contextCategoryId=43791&ref=25 Preoperative povidone-iodine and postoperative intracameral antibiotic injections are recommended for endophthalmitis prophylaxis, claims a recent paper. 2013-01-22T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032013/802869null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/MICS-IOL-modification-does-not-affect-PCO/ArticleStandard/Article/detail/801329?contextCategoryId=43791&ref=25 Modifying a MICS IOL from a 3-piece to a 1-piece haptic design does not cause any significant changes in PCO amount. 2013-01-07T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/012013/801329null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Optegra-first-to-use-cataract-laser-in-UK/ArticleStandard/Article/detail/798813?contextCategoryId=43791&ref=25 Optegra is the first to offer the LensAR cataract laser in its London eye hospital. 2012-12-11T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/492012/798813null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Multiple-micro-bypass-stents-lower-IOP/ArticleStandard/Article/detail/795755?contextCategoryId=43791&ref=25 Multiple micro-bypass stents with concurrent cataract surgery lowers IOP to less than 15 mmHg in patients with open-angle glaucoma (OAG) and cataract. 2012-11-15T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/452012/795755null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Corneal-astigmatism-and-HOAs-affect-IOL-performanc/ArticleStandard/Article/detail/791126?contextCategoryId=43791&ref=25 Uncorrected corneal astigmatism and higher-order aberrations (HOAs) in pseudophakic eyes significantly affects through-focus performance of presbyopia-correcting IOLs. 2012-10-10T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/402012/791126null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Dexamethasone-protects-against-membrane-formation/ArticleStandard/Article/detail/790242?contextCategoryId=43791&ref=25 Dexamethasone protects against anterior membrane formation and doesn’t increase glaucoma risk. 2012-10-02T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/392012/790242null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/CE-Mark-for-IOL-and-delivery-system/ArticleStandard/Article/detail/788336?contextCategoryId=43791&ref=25 Abbott Medical Optics (AMO) has announced the launch and CE Mark of approval for both the Tecnis multifocal toric IOL and iTec preloaded delivery system at the ESCRS in Milan this year. 2012-09-20T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/372012/788336null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/European-approval-for-hydrophobic-acrylic-IOL/ArticleStandard/Article/detail/788330?contextCategoryId=43791&ref=25 Bausch + Lomb introduced the enVista toric IOL for astigmatism correction for European patients at the 2012 ESCRS Congress in Milan. 2012-09-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/372012/788330null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Intrastromal-corneal-ring-implant-safe/ArticleStandard/Article/detail/788325?contextCategoryId=43791&ref=25 Intrastromal corneal ring segment (ICRS) implantation is safe and offers good visual and refractive outcomes in patients with paracentral keratoconus. 2012-09-17T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/372012/788325null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Pachymetry-guided-keratoplasty-useful-for-keratoco/ArticleStandard/Article/detail/786492?contextCategoryId=43791&ref=25 Pachymetry-guided custom excimer laser–assisted lamellar keratoplasty is a useful surgical procedure for the treatment of moderate to advanced keratoconus. 2012-09-06T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/352012/786492null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/On-line-OCT-identifies-hidden-lesions/ArticleStandard/Article/detail/782798?contextCategoryId=43791&ref=25 On-line OCT identifies non-ophthalmologically visible lesions in subthreshold laser irradiation. 2012-08-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/302012/782798null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Travoprost-patient-responses-revealed/ArticleStandard/Article/detail/782796?contextCategoryId=43791&ref=25 A recent study was unable to conclude whether intraocular penetration of travoprost 0.004% was affected by central corneal thickness (CCR), potentially explaining differences in patient response to the drug. 2012-08-07T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/302012/782796null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Flexible-cannulas-safest-for-akinesia/ArticleStandard/Article/detail/782693?contextCategoryId=43791&ref=25 Flexible cannulas are safest for akinesia and anaesthesia in the latest comparison study on sub-Tenon cannulas. 2012-07-30T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/302012/782693null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/University-challenge-collaboration-for-major-eye-s/ArticleStandard/Article/detail/782182?contextCategoryId=43791&ref=25 Anglia Ruskin University is working in collaboration with the University of the West Indies to conduct the National Eye Survey of Trinidad and Tobago (NESTT). 2012-07-21T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/292012/782182null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Charity-aims-to-encourage-the-prioritization-of-si/ArticleStandard/Article/detail/781038?contextCategoryId=43791&ref=25 More attention should be paid to dealing with sight loss, claims a new report created by ocular charity Visionary. 2012-07-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/282012/781038null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Safety-first-pIOL-is-effective-for-myopic-astigmat/ArticleStandard/Article/detail/781035?contextCategoryId=43791&ref=25 Implantation of the Artiflex toric iris-fixated phakic IOL is effective, predictable and safe for the correction of myopic astigmatism. 2012-07-16T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/282012/781035null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Ophthalmic-viscosurgical-device-approved-for-catar/ArticleStandard/Article/detail/780360?contextCategoryId=43791&ref=25 The Healon Endocoat OVD, developed by Abbott, has been approved for use as a surgical aid in cataract surgery. 2012-07-12T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/272012/780360null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Cefazolin-injection-reduces-the-rate-of-postoperat/ArticleStandard/Article/detail/779522?contextCategoryId=43791&ref=25 Administering cezafolin injections after cataract surgery reduces the rate of postoperative endophthalmitis. 2012-07-05T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/262012/779522null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Novel-suturelesss-scleral-IOL-fixation-technique-s/ArticleStandard/Article/detail/779505?contextCategoryId=43791&ref=25 A novel sutureless scleral IOL fixation technique is successful in patients with insufficient posterior capsule support. 2012-06-29T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/262012/779505null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Tilt-and-decentration-of-aberration-correcting-IOL/ArticleStandard/Article/detail/778424?contextCategoryId=43791&ref=25 Aberration-correcting IOLs are more sensitive to decentration and tilt 2012-06-27T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/252012/778424null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Patching-adherence-is-linked-to-improved-grating-v/ArticleStandard/Article/detail/777522?contextCategoryId=43791&ref=25 Patching during the first six months after surgery is linked to improved grating visual acuity in infants with unilateral cataract. 2012-06-20T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/242012/777522null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/OTS-is-reliable-in-predicting-paediatric-cataract-/ArticleStandard/Article/detail/777519?contextCategoryId=43791&ref=25 The Ocular Trauma Score (OTS) is a reliable predictor of final visual outcome in children with traumatic cataract 2012-06-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/242012/777519null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Local-anaesthesia-for-cataract-surgery/ArticleStandard/Article/detail/650054?contextCategoryId=43791&ref=25 A comparative evaluation of local anaesthesia for cataract surgery, published in The Journal of Cataract & Refractive Surgery says that randomized clinical trials are needed to facilitate statistical methods of metaanalysis to establish convincingly the overall benefits and efficacy of the various local anesthesia procedures in cataract surgery. 2010-01-06T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/022010/650054null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Clinical-trials-show-promise-to-help-mydriasis-dur/ArticleStandard/Article/detail/619319?contextCategoryId=43791&ref=25 Results from the Omeros Corporation for the Phase I/Phase II clinical trial of OMS302, a proprietary combination of an anti-inflammatory agent and an agent that causes pupil dilation (mydriasis) are said to be promising. 2009-08-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/342009/619319null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Ketolorac-tromethamine-should-be-available-in-Sept/ArticleStandard/Article/detail/619320?contextCategoryId=43791&ref=25 Allergan Inc. expects its ketorolac tromethamine ophthalmic solution 0.45% (Acuvail) to be available in the United States in September. The preservative-free formulation of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the treatment of pain and inflammation after cataract surgery and received FDA approval at the end of July, the company announced. 2009-08-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/342009/619320null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Researchers-uncover-genetic-link-to-age-related-ca/ArticleStandard/Article/detail/619345?contextCategoryId=43791&ref=25 Researchers in Cleveland have discovered the first gene associated with the formation of age-related cataracts. EphA2 encodes an enzyme that plays a role in the repair of proteins in the lens of the eye after they become damaged and clump together, according to the investigators. 2009-08-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/342009/619345null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Post-cataract-surgery-pain-treatment-gets-thumbs-u/ArticleStandard/Article/detail/615860?contextCategoryId=43791&ref=25 ACUVAIL (Allergan), the ketorolac tromethamine ophthalmic solution, which acts as a treatment for inflammation and pain after cataract surgery has been approved by the FDA. 2009-08-05T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/322009/615860null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Phacoemulsification-fluidics-characterized-by-new-/ArticleStandard/Article/detail/608780?contextCategoryId=43791&ref=25 Implementation of novel techniques to analyze the fluidic signature of phacoemulsification performed using different ultrasound modalities and phaco tips is providing important insights that will be helpful for improving the efficiency and safety of lens removal surgery. 2009-07-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/282009/608780null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Cataract-surgery-pipeline/ArticleStandard/Article/detail/597503?contextCategoryId=43791&ref=25 The cataract surgery technology landscape including pipeline products at varying development stages comes under scrutiny in a new report released this month. 2009-05-13T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202009/597503null HTML http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/IOL-receives-further-40-million-investment/ArticleStandard/Article/detail/596106?contextCategoryId=43791&ref=25 Visiogen is reporting significant progress in the development of the Synchrony IOL, including the completion of the US phase III study, the formation of Visiogen Europe GmbH and the commencement of commercialization in Europe. 2009-05-06T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/182009/596106null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Managing-post-PRK-discomfort/ArticleStandard/Article/detail/588586?contextCategoryId=43791&ref=25 When treating post-phacorefractive keratectomy (PRK) discomfort, there are no significant differences in either safety or efficacy between bromfenac twice-daily and ketorolac four times daily, according to a study published in the February issue of the Journal of Refractive Surgery. 2009-03-25T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/132009/588586null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Alcon-IQ-approved-in-US/ArticleStandard/Article/detail/585402?contextCategoryId=43791&ref=25 The aspheric AcrySof IQ Toric intraocular lens (Alcon Inc) has been approved by the FDA, and will shortly be available to provide improved distance vision to patients with cataract and astigmatism. 2009-03-11T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102009/585402null HTML http://www.oteurope.com/ophthalmologytimeseurope/Ophthalmology+industry+news/BampL-signs-agreements-with-Pfizer-and-Santen/ArticleStandard/Article/detail/585389?contextCategoryId=43791&ref=25 Pfizer and Bausch & Lomb are to co-promote their prescription eye drugs in the United States, allowing both companies to increase significantly the support for the products, according to a joint statement released by the companies. 2009-03-11T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102009/585389null HTML http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Single-Use-Instrument-recommendations-set-to-stimu/ArticleStandard/Article/detail/583737?contextCategoryId=43791&ref=25 The recommendations for 'the use of single use instruments where possible' when performing 'high-risk' surgical procedures, has not only led to a growth in the single use market segment, but has stimulated massive reform in decontamination procedures, creating increased demand globally for reusable instruments due to new processes and longer lead times. 2009-03-04T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/092009/583737null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Zeiss-launches-phaco-system-for-emerging-markets/ArticleStandard/Article/detail/581662?contextCategoryId=43791&ref=25 Visalis 100, a surgical cataract treatment system, has been launched by Carl Zeiss Meditec at the All India Ophthalmology Congress (AIOC), held February 5–8 in Jaipur. The system was presented in India as it has been designed specifically to be used by doctors in emerging markets. 2009-02-18T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082009/581662null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Anti-inflammatory-enters-Phase-III/ArticleStandard/Article/detail/580358?contextCategoryId=43791&ref=25 ESBA105, an anti-TNF alpha antibody fragment designed to reduce inflammation in patients undergoing cataract surgery, has begun a Phase Ib/IIa trial, according to an announcement from ESBATech AG, the antibody's developer. 2009-02-11T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072009/580358null HTML http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Phaco-does-not-boost-AMD-progression/ArticleStandard/Article/detail/580357?contextCategoryId=43791&ref=25 No clear link between cataract surgery and progressive age-related macular degeneration (AMD) could be established by a study published in the February issue of Ophthalmology. 2009-02-11T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072009/580357null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/OptiMedica-donates-photocoagulator-to-ORBIS/ArticleStandard/Article/detail/578726?contextCategoryId=43791&ref=25 OptiMedica Corp has donated a PASCAL photocoagulator to non-profit organization ORBIS International, under a new partnership between the two companies. 2009-02-04T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/062009/578726null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Treating-uveitis-with-phaco/ArticleStandard/Article/detail/577234?contextCategoryId=43791&ref=25 Phacoemulsification can increase visual acuity in uveitis patients, concluded a study published in the January issue of the British Journal of Ophthalmology. 2009-01-28T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/042009/577234null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Blood-thinners-increase-perioperative-complication/ArticleStandard/Article/detail/576013?contextCategoryId=43791&ref=25 Use of warfarin or clopidogrel is associated with a significant increase in non-sight-threatening complications during cataract surgery, concluded a study published in the January issue of Eye. 2009-01-21T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/042009/576013null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Tecnis-multifocal-approved-by-FDA/ArticleStandard/Article/detail/576022?contextCategoryId=43791&ref=25 The Tecnis multifocal intraocular lens (IOL) has been approved by the FDA, according to an announcement made by AMO, the manufacturer of the lens. 2009-01-21T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/042009/576022null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Astigmatism-in-cataract-patients/ArticleStandard/Article/detail/574823?contextCategoryId=43791&ref=25 Most candidates for cataract surgery have a degree of corneal astigmatism, which should be considered by intraocular lens (IOL) manufacturers, concluded a study published in the January issue of the Journal of Cataract & Refractive Surgery. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574823null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Reducing-phaco-induced-apoptosis/ArticleStandard/Article/detail/574866?contextCategoryId=43791&ref=25 Cell apoptosis caused by free-radical formation during phacoemulsification can be mediated by the introduction of ascorbic acid, according to a study published in the December 2008 issue of the Journal of Cataract & Refractive Surgery. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574866null HTML http://www.oteurope.com/ophthalmologytimeseurope/Ophthalmology+industry+news/AMO-to-be-acquired-by-Abbott/ArticleStandard/Article/detail/574817?contextCategoryId=43791&ref=25 Advanced Medical Optics (AMO) has been acquired by Abbott, a global pharmaceutical and medical device company, the companies have announced in a statement. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574817null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/The-impact-of-fungal-endophthalmitis/ArticleStandard/Article/detail/574872?contextCategoryId=43791&ref=25 A great variety of fungal agents may cause endophthalmitis, and accurate diagnosis is essential for effective treatment, according to a study published in the November/December 2008 issue of Retina. 2009-01-14T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/032009/574872null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Is-cataract-surgery-conducted-more-frequently-than/ArticleStandard/Article/detail/573878?contextCategoryId=43791&ref=25 It is difficult to determine whether or not cataract surgery is being used more frequently in the UK than is necessary, according to study results published in the January 2009 issue of the British Journal of Ophthalmology. 2009-01-08T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/022009/573878null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Novel-conjunctivitis-drug-recommended-by-FDA/ArticleStandard/Article/detail/571651?contextCategoryId=43791&ref=25 Besifloxacin ophthalmic suspension 0.6% (Bausch & Lomb) has been recommended by the FDA for the treatment of bacterial conjunctivitis. 2008-12-17T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/512008/571651null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Xibrom-performs-well-at-Phase-III/ArticleStandard/Article/detail/569936?contextCategoryId=43791&ref=25 Xibrom (bromfenac sodium ophthalmic solution) 0.09% (ISTA Pharmaceuticals, Inc.) achieved the primary endpoint of its Phase III trial: absence of ocular inflammation 15 days postoperatively. 2008-12-10T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/492008/569936null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/B-MICS-better-than-C-SICS/ArticleStandard/Article/detail/568592?contextCategoryId=43791&ref=25 Biaxial microincision cataract surgery (B-MICS) is more successful than traditional cataract surgery in improving optical performance and reducing higher order aberrations, according to study results published in the December issue of the British Journal of Ophthalmology. 2008-12-03T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/482008/568592null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Anaesthesia-application-modes-compared/ArticleStandard/Article/detail/567588?contextCategoryId=43791&ref=25 Contact anaesthesia is just as safe and effective as peribulbar application for combined cataract and glaucoma surgery, according to study results published online ahead of print by Ophthalmologica. 2008-11-26T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/472008/567588null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Investigating-Collamers-accommodation/ArticleStandard/Article/detail/567522?contextCategoryId=43791&ref=25 STAAR Surgical has created the Collamer Accommodating Study Team (CAST), a group of seven ophthalmologists who will investigate the accommodative properties of STAAR's Collamer intraocular lens (IOL). 2008-11-26T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/472008/567522null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Alcon-launches-patient-education-tool/ArticleStandard/Article/detail/565177?contextCategoryId=43791&ref=25 CataractSurgery.com, an online resource for patient education, has been launched by Alcon, Inc. 2008-11-17T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/462008/565177null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/AMO-limited-recall-of-Healon-D/ArticleStandard/Article/detail/565186?contextCategoryId=43791&ref=25 Following limited reports of adverse events encountered by US physicians using a particular batch of Healon D viscoelastic, AMO has recalled the remaining products in the batch. 2008-11-17T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/462008/565186null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Phaco-decreases-mortality/ArticleStandard/Article/detail/561751?contextCategoryId=43791&ref=25 Contrary to accepted wisdom, cataract surgery decreases mortality rates, according to results published online ahead of print by the British Journal of Ophthalmology. 2008-11-03T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/442008/561751null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Artificial-tears-contamination-risk/ArticleStandard/Article/detail/561852?contextCategoryId=43791&ref=25 Multiple-use packs of preservative-free artificial tears are susceptible to contamination, according to study results published in the November issue of the British Journal of Ophthalmology. 2008-11-03T05:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/442008/561852null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/iSpheric-gains-US-approval/ArticleStandard/Article/detail/560778?contextCategoryId=43791&ref=25 The iSpheric Model YA-60BB intraocular lens (IOL) (Hoya) has received FDA approval. 2008-10-27T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/432008/560778null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/New-anaesthetic-approved/ArticleStandard/Article/detail/558845?contextCategoryId=43791&ref=25 Akten Ophthalmic Gel 3.5%, a topical anaesthetic for the eye, has become the first new ocular anaesthetic to receive FDA approval in 40 years, according to a statement released by Akorn, Inc, the maker of Akten. 2008-10-20T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/422008/558845null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Alcon-joins-forces-with-pharma-giant/ArticleStandard/Article/detail/558882?contextCategoryId=43791&ref=25 Alcon is continuing to invest heavily in its future drug portfolio by forging links with GlaxoSmithKline (GSK) for the global ophthalmic rights to cilomilast, a phosphodiesterase IV inhibitor, and by expanding an existing alliance with Origenis GmbH for the discovery and development of small molecules. 2008-10-20T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/422008/558882null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/AMO-viscoelastic-gains-FDA-approval/ArticleStandard/Article/detail/557127?contextCategoryId=43791&ref=25 Healon D latex-free viscoelastic (AMO) has been granted premarket approval by the FDA. The clear dispersive ophthalmic viscosurgical device (OVD) is designed to be used during phacoemulsification, intraocular lens (IOL) implantation, keratoplasty and glaucoma filtration surgery. 2008-10-13T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/412008/557127null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Postop-inflammation-amp-pain-drug-launched/ArticleStandard/Article/detail/557139?contextCategoryId=43791&ref=25 Durezol 0.05% (difluprednate ophthalmic emulsion; Sirion Therapeutics Inc), a topical corticosteroid to treat postoperative ocular inflammation and pain, is now commercially available, following FDA approval in June 2008. 2008-10-13T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/412008/557139null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Caffeine-prevents-cataracts/ArticleStandard/Article/detail/555561?contextCategoryId=43791&ref=25 Consumption of caffeine prevents against the formation of cataracts due to ultraviolet (UV) light radiation, according to study results published in the October edition of the Journal of Ocular Pharmacology and Therapeutics. 2008-10-06T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/402008/555561null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Good-VA-means-good-stereopsis-in-children/ArticleStandard/Article/detail/552554?contextCategoryId=43791&ref=25 Postoperative visual acuity (VA) is the factor with the most significant impact on stereopsis in paediatric unilateral pseudophakic subjects, according to study results published online ahead of print by the British Journal of Ophthalmology. 2008-09-29T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/392008/552554null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Presoaked-IOLs-show-dual-action/ArticleStandard/Article/detail/552601?contextCategoryId=43791&ref=25 Intraocular lenses (IOLs) soaked in antibiotics have antimicrobial properties, according to results published in the October issue of the Journal of Ocular Pharmacology and Therapeutics. 2008-09-29T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/392008/552601null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Indian-doctor-eyes-world-record/ArticleStandard/Article/detail/551540?contextCategoryId=43791&ref=25 An Indian doctor is planning to perform 200 cataract extractions free of cost within 15 hours in November in order to secure a place in the Guinness Book of World Records. 2008-09-23T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/382008/551540null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Third--vs-fourth-generation-quinolones-which-are-b/ArticleStandard/Article/detail/547684?contextCategoryId=43791&ref=25 According to a study published in the September issue of the Journal of Cataract and Refractive Surgery, differences in the pharmacokinetic and pharmacodynamic properties of quinolone antibiotics may affect the incidence of endophthalmitis following cataract surgery. 2008-09-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/362008/547684null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Tamsulosin-ups-IFIS-risk-by-more-than-50/ArticleStandard/Article/detail/545127?contextCategoryId=43791&ref=25 Tamsulosin increases the risk of intraoperative floppy iris syndrome (IFIS) during cataract surgery by more than 50%, according to results of a study published online ahead of print by Acta Ophthalmologica. 2008-09-01T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/352008/545127null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Best-mode-for-treating-hard-cataracts/ArticleStandard/Article/detail/545132?contextCategoryId=43791&ref=25 The "multiburst" mode of bimanual microincision phacoemulsification machines is unsuitable for treating cataracts with a nuclear density of Grade 3 and above, according to study results published in the July 2008 issue of Clinical & Experimental Ophthalmology. 2008-09-01T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/352008/545132null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Steroid-cataracts-in-children/ArticleStandard/Article/detail/543435?contextCategoryId=43791&ref=25 Paediatric subjects who require frequent steroid therapy are at an increased risk of developing amblyopia due to cataracts, according to a study published online ahead of print by Pediatrics International, the official English language publication of the Japan Pediatric Society. 2008-08-25T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/342008/543435null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Control-charts-diagnose-endophthalmitis/ArticleStandard/Article/detail/543447?contextCategoryId=43791&ref=25 Control charts are an accurate way of measuring disparity in endophthalmitis following phacoemulsification, according to a study published online ahead of print by Eye. 2008-08-25T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/342008/543447null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Paediatric-patching-not-necessary/ArticleStandard/Article/detail/542330?contextCategoryId=43791&ref=25 Early unilateral cataract surgery in infants can produce good visual outcomes even if patching is discontinued, according to a study in the August 2008 issue of the Archives of Ophthalmology. 2008-08-18T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/332008/542330null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Best-phaco-disinfection-techniques/ArticleStandard/Article/detail/534485?contextCategoryId=43791&ref=25 Three-day application of levofloxacin in the presence of polyvinyl alcohol-iodine or povidone iodine offers the best infection control in phaco patients, according to a study published in the May 2008 issue of the Japanese Journal of Ophthalmology. 2008-08-11T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/322008/534485null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/STAAR-lenses-granted-NTIOL-status/ArticleStandard/Article/detail/532704?contextCategoryId=43791&ref=25 The Afinity Collamer aspheric single piece Intraocular Lens (IOL) Model CC4204A and the Elastimide Silicone aspheric IOL Model AQ2015A, both manufactured and marketed by STAAR Surgical, have been designated New Technology IOLs (NTIOLs) by the US Centers for Medicare and Medicaid. 2008-08-04T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/312008/532704null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/MICS-gauge-width-impacts-wound/ArticleStandard/Article/detail/531124?contextCategoryId=43791&ref=25 Gauges and knives used during microincision cataract surgery (MICS) should be of equal thickness, according to a study published in the July 2008 issue of the Journal of Cataract & Refractive Surgery. 2008-07-28T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/302008/531124null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Oertli-launches-next-generation-microincision-inst/ArticleStandard/Article/detail/527625?contextCategoryId=43791&ref=25 Oertli has launched new instruments to be used in microincision surgery for the anterior and the posterior segments. 2008-07-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/272008/527625null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Fourth-generation-accommodating-IOL-gets-FDA-ok/ArticleStandard/Article/detail/527556?contextCategoryId=43791&ref=25 The fourth-generation Crystalens HD (Bausch & Lomb) accommodating intraocular lens (IOL) has received FDA marketing approval, five years after the lens was initially launched on the market. 2008-07-08T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/272008/527556null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Alcon-and-AMO-to-cross-license-IOL-patents/ArticleStandard/Article/detail/526206?contextCategoryId=43791&ref=25 Alcon and Advanced Medical Optics (AMO) are to share proprietary information on their designs for intraocular lenses (IOL). 2008-06-30T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/262008/526206null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Postoperative-pain-steroid-approved/ArticleStandard/Article/detail/526207?contextCategoryId=43791&ref=25 Durezol (difluprednate ophthalmic emulsion; Sirion Therapeutics) 0.05%, a topical steroid, has received US Food and Drug Administration (FDA) approval for the treatment of postoperative ocular inflammation and pain. 2008-06-30T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/262008/526207null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/NSAID-activity-at-trough-drug-levels/ArticleStandard/Article/detail/524918?contextCategoryId=43791&ref=25 Animals undergoing lens removal surgery were treated with non-steroidal anti-inflammatory drugs pre- and postoperatively. On the first day after surgery, aqueous humor samples were taken at times corresponding to trough drug levels. The mean aqueous prostaglandin E2 concentration was significantly lower in animals being treated with ketorolac 0.4% (Acular LS, Allergan) compared with those receiving bromfenac 0.09% (Xibrom, ISTA Pharmaceuticals). 2008-06-23T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/252008/524918null XML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Endophthalmitis-prophylaxis-limited-evidence-fuels/ArticleStandard/Article/detail/524906?contextCategoryId=43791&ref=25 Few well-designed studies evaluate endophthalmitis prophylaxis. Available evidence suggests a role for intracameral cefuroxime. The benefit must be weighed against the potential risk of errors in formulation, however. 2008-06-23T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/252008/524906null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Multifocal-IOLs-in-glaucoma-patients/ArticleStandard/Article/detail/523710?contextCategoryId=43791&ref=25 Further study is needed to establish the role of multifocal IOLs in eyes with glaucomatous damage, according to Ike Ahmed, MD, who was speaking during the glaucoma subspecialty day at the annual meeting of the American Society of Cataract and Refractive Surgery. 2008-06-16T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/242008/523710null XML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Advanced-glycation-in-diabetic-patients-leads-to-c/ArticleStandard/Article/detail/523705?contextCategoryId=43791&ref=25 The higher level of advanced glycation end products (AGE) in senile diabetic patients may correlate to a higher rate of cataract development, according to a study published in the May?June 2008 issue of the Journal of Diabetes and its Complications. 2008-06-16T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/242008/523705null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/BampL-to-stay-private-for-5-years-or-more/ArticleStandard/Article/detail/522036?contextCategoryId=43791&ref=25 Bausch & Lomb (B&L) bought by Warburg Pincus last October has a long-term growth plan and will not return to the public market any time soon, said Gerry Ostrov, chief executive officer, B&L. 2008-06-10T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/232008/522036null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Anaesthesia-complication-rates/ArticleStandard/Article/detail/520033?contextCategoryId=43791&ref=25 Anaesthesia administered by sharp needles carries a greater risk of serious complications than subtenons cannula administration, according to a study published online ahead of print in Eye. 2008-06-03T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/222008/520033null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/No-consistency-in-endophthalmitis-prophylaxis/ArticleStandard/Article/detail/518064?contextCategoryId=43791&ref=25 Methods of attempting to prevent postoperative endophthalmitis vary widely across the United Kingdom, according to a study published in the May 2008 issue of Eye. 2008-05-28T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/212008/518064null HTML http://www.oteurope.com/ophthalmologytimeseurope/Refractive+news/Phakic-IOLs--long-term-failures/ArticleStandard/Article/detail/518065?contextCategoryId=43791&ref=25 Phakic intraocular lenses (IOLs) have failed to live up to their promise, according to an opinion expressed at this year's meeting of the French Society of Ophthalmology (SFO). 2008-05-28T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/212008/518065null HTML http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Is-cataract-surgery-the-best-way-to-lower-IOP/ArticleStandard/Article/detail/517625?contextCategoryId=43791&ref=25 Extraction of cataracts lowers intraocular pressure (IOP) to normal levels in glaucoma patients, and may in fact be a better treatment option than combined surgery, according to a study presented at this year's meeting of the Italian Society of Ophthalmology. 2008-05-22T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/212008/517625null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/IOL-type-increases-capsular-block-risk/ArticleStandard/Article/detail/516227?contextCategoryId=43791&ref=25 The incidence of capsular block syndrome (CBS), although rare, can be increased by design features of lenses implanted during cataract surgery, according to a study published in the March 2008 issue of the Journal of Cataract & Refractive Surgery. 2008-05-19T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202008/516227null HTML http://www.oteurope.com/ophthalmologytimeseurope/Refractive+news/Post-LASIK-contact-lens-launched/ArticleStandard/Article/detail/514934?contextCategoryId=43791&ref=25 A hybrid contact lens designed for eyes that have suffered corneal trauma or undergone either refractive surgery or penetrating keratoplasty has been launched by SynergEyes Inc, US. The SynergEyes PS lens can also be used in eyes with degenerative corneal conditions. 2008-05-12T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192008/514934null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Vitamin-E-has-no-role-in-cataract-prevention/ArticleStandard/Article/detail/515109?contextCategoryId=43791&ref=25 Vitamin E supplements do not help to prevent cataract, according to a study published in the May 2008 issue of Ophthalmology. 2008-05-12T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192008/515109null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Levofloxacin-more-effective-than-vancomycin/ArticleStandard/Article/detail/515108?contextCategoryId=43791&ref=25 Levofloxacin is a viable treatment for endophthalmitis, according to a study published online ahead of print by the British Journal of Ophthalmology. 2008-05-12T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192008/515108null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Cataracts-may-be-caused-by-crystallin-interactions/ArticleStandard/Article/detail/514009?contextCategoryId=43791&ref=25 Cataractogenesis may be the result of the interaction of crystallin-derived peptides with intact crystallins in the lens, according to a study published in the March 2008 issue of the Journal of Biological Chemistry. 2008-05-06T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/182008/514009null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Meeting-of-the-American-Society-of-Cataract-amp-Re/ArticleStandard/Article/detail/513203?contextCategoryId=43791&ref=25 Highlights from the ASCRS meeting, held 4–8 April 2008, Chicago, US. 2008-05-01T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/182008/513203null HTML http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Canaloplasty-popularity-growing/ArticleStandard/Article/detail/512953?contextCategoryId=43791&ref=25 Canaloplasty with tensioning suture placement is growing in popularity owing to a combination of factors, including a successful training programme, an improved reimbursement picture, and favourable long-term data, said Richard A. Lewis, MD. 2008-05-01T04:00:00Z http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/182008/512953null HTML